Skip to content

Public FDA record

Z-2244-2020: Cardiovascular Monitoring Device accessory - Product Usage: The chest pneumograph (also referred to as th

Recall record Z-2244-2020 for Philips North America, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2244-2020
Company in FDA record
Philips North America, LLC
FDA record creation date
Jun 2, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The labeling of the Philips Chest Pneumograph does not include a statement indicating that the product contains natural rubber latex.

Source facts

Action
In March of 2020 Philips Healthcare sent out an Urgent Medical Device Corrective Action Notice identifying the problem, under what circumstances it can occur, the actions that should be taken by the customer/user to prevent risks for patients/users, and the actions planned by Philips to correct the problem. PRODUCTS: All Pneumograph, chest, NM, 3160 with part #94023 are affected. ACTIONS TO BE TAKEN: Customers/users are asked to review the Notification letter and share with all members of staff who utilize this product. Customers/Users should also retain a copy with the equipment Instructions for Use. The chest pneumograph can continue to be used for monitoring as directed by a physician. 1.Identify all affected chest pneumographs in your facility using the guidelines provided in the HOW TO IDENTIFY AFFECTED PRODUCTS section above.Do not return any product to Philips. 2. Complete and sign the reply form provided on the last page of this letter. 3. Send the completed and signed reply form to Philips via the contact information located on the form. 4. Upon receipt of the reply form, Philips will send you one kit per chest pneumograph in your possession along with instructions for labeling each chest pneumograph. 5. Upon receipt of the kit, follow the included instructions to label each chest pneumograph in your possession. The label to be added identifies the product as containing latex. ACTIONS PLANNED BY PHILIPS: Upon receipt of the completed and signed reply form, Philips will provide one kit per chest pneumograph in each customers possession for the purposes of labeling each affected chest pneumograph. This kit will be provided free of charge.
Initiated
2020-04-13
Root cause
Under Investigation by firm
Terminated
2023-04-14
Distribution
US Nationwide distribution.
Recall number
Z-2244-2020
Recall status
Terminated
CDRH record ID
181238
FDA record created
2020-06-02
Recall event number
85560

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗